Clinical trial
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
NCT00994916 is registered in ClinicalTrials.gov with David Lacomis, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
- Lead sponsor
- David Lacomis, MD
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.